An observational study in Vascular Access, sponsored by Christie Medical Holdings, Inc.. Completed at 2 sites in United States. Per ClinicalTrials.gov, last updated 2014-02-03.
Sponsored by Christie Medical Holdings, Inc. · Observational
The objective of this study is to show VeinViewer® Vision is an effective vein visualization device for peripheral vascular access, pre-, during, and post access.
Christie Medical Holdings, Inc. is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients at a medical facility requiring IV access.
Exclusion Criteria:
Standard IV Access without device
IV access with VeinViewer device
The primary endpoint will be total number of attempts for successful cannulation.
Time frame: 1 day
Amount of time for successful venous access
Time frame: 1 day
This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Christie Medical Holdings, Inc.